Cas no 1291486-73-1 (methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate)
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
- 1291486-73-1
- Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)-thiophene-2-carboxylate
- AKOS005738877
- CS-0324599
- BS-3289
- STL112413
- methyl 4-(4-chlorophenyl)-3-chlorosulfonylthiophene-2-carboxylate
- methyl4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
-
- MDL: MFCD18804127
- Inchi: 1S/C12H8Cl2O4S2/c1-18-12(15)10-11(20(14,16)17)9(6-19-10)7-2-4-8(13)5-3-7/h2-6H,1H3
- InChI Key: RSZCVQYNVROMAZ-UHFFFAOYSA-N
- SMILES: ClS(C1=C(C(=O)OC)SC=C1C1C=CC(=CC=1)Cl)(=O)=O
Computed Properties
- Exact Mass: 349.9241065Da
- Monoisotopic Mass: 349.9241065Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 20
- Rotatable Bond Count: 4
- Complexity: 455
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.1
- Topological Polar Surface Area: 97.1?2
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B495913-10mg |
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 10mg |
$ 50.00 | 2022-06-07 | ||
| TRC | B495913-50mg |
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 50mg |
$ 210.00 | 2022-06-07 | ||
| TRC | B495913-100mg |
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 100mg |
$ 320.00 | 2022-06-07 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1395269-250mg |
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 95+% | 250mg |
¥2822.00 | 2024-08-09 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1395269-1g |
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 95+% | 1g |
¥5443.00 | 2024-08-09 | |
| Ambeed | A370595-1g |
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 95+% | 1g |
$538.0 | 2024-04-24 | |
| A2B Chem LLC | AI29132-1mg |
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 1mg |
$146.00 | 2024-01-04 | ||
| A2B Chem LLC | AI29132-5mg |
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 5mg |
$170.00 | 2024-01-04 | ||
| A2B Chem LLC | AI29132-10mg |
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 10mg |
$182.00 | 2024-01-04 | ||
| A2B Chem LLC | AI29132-20mg |
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate |
1291486-73-1 | 20mg |
$205.00 | 2024-01-04 |
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Related Literature
-
Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
-
Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
-
Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
-
Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
Additional information on methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
Research Briefing on Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate (CAS: 1291486-73-1)
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate (CAS: 1291486-73-1) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its thiophene core and chlorosulfonyl functional group, serves as a versatile intermediate in the synthesis of biologically active molecules. Recent studies have explored its potential applications in drug discovery, particularly in the development of enzyme inhibitors and antimicrobial agents.
The compound's unique structural features, including the presence of a chlorophenyl group and a chlorosulfonyl moiety, contribute to its reactivity and potential as a building block for more complex molecules. Researchers have investigated its utility in the synthesis of thiophene-based derivatives, which are known for their diverse pharmacological activities. Recent publications highlight its role in the development of novel therapeutic agents targeting infectious diseases and metabolic disorders.
One of the key areas of interest is the compound's application in the synthesis of sulfonamide derivatives. Sulfonamides are a well-known class of compounds with broad-spectrum biological activities, including antibacterial, antifungal, and antiviral properties. The chlorosulfonyl group in methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate provides a reactive site for the introduction of various amine functionalities, enabling the creation of diverse sulfonamide libraries for high-throughput screening.
Recent advancements in synthetic methodologies have facilitated the efficient preparation of this compound and its derivatives. A study published in the Journal of Medicinal Chemistry (2023) demonstrated a streamlined synthetic route for methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate, achieving high yields and purity. The researchers emphasized the compound's stability under various reaction conditions, making it a reliable intermediate for further functionalization.
In addition to its synthetic utility, the compound has been evaluated for its direct biological activities. Preliminary in vitro studies have shown that methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate exhibits moderate inhibitory effects against certain bacterial strains, including Staphylococcus aureus and Escherichia coli. These findings suggest its potential as a lead compound for the development of new antimicrobial agents, particularly in the face of rising antibiotic resistance.
Furthermore, computational studies have been conducted to explore the compound's binding interactions with various biological targets. Molecular docking simulations revealed favorable interactions with the active sites of several enzymes, including dihydrofolate reductase (DHFR) and carbonic anhydrase. These insights provide a foundation for the rational design of more potent and selective inhibitors based on the thiophene scaffold.
Despite its promising attributes, challenges remain in optimizing the compound's pharmacokinetic properties, such as solubility and metabolic stability. Ongoing research aims to address these limitations through structural modifications and formulation strategies. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinically relevant therapeutics.
In conclusion, methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate (CAS: 1291486-73-1) represents a valuable tool in medicinal chemistry, offering diverse opportunities for drug discovery and development. Its synthetic versatility, combined with its inherent biological activity, positions it as a key player in the search for novel therapeutic agents. Future research will likely focus on expanding its applications and overcoming current limitations to fully realize its potential in the pharmaceutical industry.
1291486-73-1 (methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate) Related Products
- 1173018-95-5(ethyl 3-chlorosulfonylthiophene-2-carboxylate)
- 113387-58-9(Methyl 3-(Chlorosulfonyl)-5-phenylthiophene-2-carboxylate)
- 190375-01-0(2-Thiophenecarboxylic acid, 3-(chlorosulfonyl)-4-methyl-, ethyl ester)
- 59337-92-7(2-Carbomethoxy-3-thiophenesulfonyl chloride)
- 306935-98-8(2-Thiophenecarboxylicacid, 3-(chlorosulfonyl)-4-phenyl-5-(trifluoromethyl)-, methyl ester)
- 158439-31-7(Methyl 5-chloro-3-(chlorosulfonyl)thiophene-2-carboxylate)
- 1291487-04-1(methyl 3-(chlorosulfonyl)-4-(3-fluorophenyl)thiophene-2-carboxylate)
- 1089330-66-4(4-(4-Chloro-phenyl)-3-chlorosulfonyl-5-trifluoro-methyl-thiophene-2-carboxylic acid methyl ester)
- 100567-24-6(2-Thiophenecarboxylic acid, 3-(chlorosulfonyl)-4-phenyl-, methyl ester)
- 126910-68-7(Methyl 5-chloro-3-(chlorosulfonyl)thiophene-2-carboxylate)